Jon Lømo

Oslo University Hospital — Norway

Medicine · Health Sciences

21h-index1.4kcitations68works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Lesions and Carcinomas(9), Breast Cancer Treatment Studies(8), Cancer Immunotherapy and Biomarkers(7), Cancer Cells and Metastasis(6), Cancer Risks and Factors(6)

Publications68 total

A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits
JHEP Reports·2025Open Access
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
Communications Medicine·2025· 2 citedOpen Access
Abstract P1-06-28: Assessment of the immune microenvironment of the breast cancer PAM50 Subtypes – a deconvolution approach
Clinical Cancer Research·2025
Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes
BJC Reports·2025Open Access
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives
Clinical Breast Cancer·2025· 2 citedOpen Access
Abstract C013: Single cell analysis reveals tumor size-driven immune changes in primary breast tumors and corresponding lymph nodes
Cancer Research·2024
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the <scp>ALICE</scp> and <scp>ICON</scp> trials
Molecular Oncology·2024· 12 citedOpen Access
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
ESMO Open·2024· 11 citedOpen Access
Author response for "Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the &lt;scp&gt;ALICE&lt;/scp&gt; and &lt;scp&gt;ICON&lt;/scp&gt; trials"
2024
Abstract PD11-11: PD11-11 Results from ALICE – Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple Negative Breast Cancer, a Randomized Phase IIb Trial
Cancer Research·2023
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Nature Medicine·2022· 76 citedOpen Access
Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
European Journal of Nutrition·2022· 3 citedOpen Access
Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
Cell Reports Medicine·2021· 9 citedOpen Access
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
British Journal Of Nutrition·2020· 9 citedOpen Access
Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
2020· 1 citedOpen Access
Abstract P1-13-01: Lipoprotein and metabolite responses to physical exercise during adjuvant breast cancer treatment
Cancer Research·2020
Rettelse: Kosmetiske brystimplantater og brystkreft
Tidsskrift for Den norske legeforening·2020Open Access
Functional Diagnostics Using Fresh Uncultured Lung Tumor Cells to Guide Personalized Treatments
SSRN Electronic Journal·2020· 1 citedOpen Access
Kosmetiske brystimplantater og brystkreft
Tidsskrift for Den norske legeforening·2020· 6 citedOpen Access
Abstract GS5-02: Cardiovascular function and the effect of exercise training during adjuvant breast cancer treatment. Results from The EBBA-II trial
Cancer Research·2019
page 1 of 4Next →

Frequent Co-authors

Erlend B. Smeland(11), Heidi Kiil Blomhoff(9), Øystein Garred(9), Inger Thune(9), Anne McTiernan(7), Hanne Frydenberg(7), Jan Mæhlen(6), Anders Husøy(5), Morten Wang Fagerland(5), Bjørn Naume(5), Ragnhild E. Paulsen(5), Vidar G. Flote(5), Ellen Schlichting(5), Frøydis Fjeldheim(4), Ellen Schlichting(4), Steinar Lundgren(4), Erik A. Wist(4), Bjørnar Gilje(4), Ragnhild Sørum Falk(4), Petra Aden(4)